BrainStorm Cell Therapeutics
BCLI
#10103
Rank
A$11.35 M
Marketcap
$1.74
Share price
14.87%
Change (1 day)
-85.94%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -A$17.71 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. . The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 -A$18.07 Million
2022 -A$37.74 Million-0.74%
2021 -A$38.02 Million-23.12%
2020 -A$49.45 Million36.8%
2019 -A$36.15 Million66.71%
2018 -A$21.68 Million181.66%
2017 -A$7.7 Million-0.6%
2016 -A$7.75 Million-41.31%
2015 -A$13.2 Million-8.22%
2014 -A$14.38 Million89.74%
2013 -A$7.58 Million42.27%
2012 -A$5.33 Million-12.45%
2011 -A$6.09 Million63.04%
2010 -A$3.74 Million35.52%
2009 -A$2.76 Million-48.99%
2008 -A$5.4 Million-44.39%
2007 -A$9.71 Million
2005 -A$5.03 Million-91.44%
2004 -A$58.73 Million94007.62%
2003 -A$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$1.07 B-6,036.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.92 Billion 4,972.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.23 Billion 6,701.82%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.96 B-16,498.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.18 Billion 886.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.4 Billion 2,098.13%๐Ÿ‡บ๐Ÿ‡ธ USA